AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Silence Therapeutics plc

Report Publication Announcement Jun 3, 2013

33536_agm-r_2013-06-03_ca41b919-c3ac-476b-8343-4d54fed436cb.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1317G

Silence Therapeutics PLC

03 June 2013

Notice of General Meeting and Annual Report

03 June 2013

Silence Therapeutics plc (AIM: SLN) announces that its Annual Report & Accounts for the year ended 31 December 2012 and the 2013 Annual General Meeting (AGM) notice were posted to shareholders today. The Annual Report & Accounts for the year ended 31 December 2012 will shortly be available for download at the Company's website www.silence-therapeutics.com 

The 2013 AGM will be held at Silence Therapeutics plc, 3 Shortlands Way, London, W6 8DA on 26 June 2013 at 11.00am.

Silence Therapeutics

Ali Mortazavi, chief executive/Timothy Freeborn, finance director +44 (0)333 988 0140

[email protected]

[email protected]

N+1 Singer

Shaun Dobson/Jenny Wyllie

+44 20 7496 3000

[email protected]

[email protected]

This information is provided by RNS

The company news service from the London Stock Exchange

END

NOASSLFSDFDSEEM

Talk to a Data Expert

Have a question? We'll get back to you promptly.